{"id":"https://openalex.org/W2082201249","doi":"https://doi.org/10.2133/dmpk.23.115","title":"The Effect of Bucolome, a CYP2C9 Inhibitor, on the Pharmacokinetics of Losartan","display_name":"The Effect of Bucolome, a CYP2C9 Inhibitor, on the Pharmacokinetics of Losartan","alternate_titles":[],"publication_year":2008,"publication_date":"2008-01-01","ids":{"openalex":"https://openalex.org/W2082201249","doi":"https://doi.org/10.2133/dmpk.23.115","mag":"2082201249","pmid":"https://pubmed.ncbi.nlm.nih.gov/18445991"},"language":"en","primary_location":{"id":"doi:10.2133/dmpk.23.115","doi":"https://doi.org/10.2133/dmpk.23.115","is_oa":false,"landing_page_url":"https://doi.org/10.2133/dmpk.23.115","pdf_url":null,"source":{"id":"https://openalex.org/S185835163","display_name":"Drug Metabolism and Pharmacokinetics","issn_l":"1347-4367","issn":["1347-4367","1880-0920"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Metabolism and Pharmacokinetics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2082201249"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101614220","display_name":"Mariko Kobayashi","orcid":"https://orcid.org/0000-0002-1345-2685","observed_orcids":["https://orcid.org/0000-0002-1345-2685"]},"institutions":[{"id":"https://openalex.org/I114838220","display_name":"Niigata University of Pharmacy and Medical and Life Sciences","ror":"https://ror.org/00dnbtf70","country_code":"JP","type":"education","lineage":["https://openalex.org/I114838220"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Mariko Kobayashi","raw_affiliation_strings":["Department of Pharmaceutical Sciences, Niigata University of Pharmacy and Applied Life Sciences, Niigata, Japan","Department of Pharmaceutical Sciences, Niigata University of Pharmacy and Applied Life Sciences"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Sciences, Niigata University of Pharmacy and Applied Life Sciences, Niigata, Japan","institution_ids":["https://openalex.org/I114838220"]},{"raw_affiliation_string":"Department of Pharmaceutical Sciences, Niigata University of Pharmacy and Applied Life Sciences","institution_ids":["https://openalex.org/I114838220"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111960378","display_name":"Kyoko Fukumoto","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114838220","display_name":"Niigata University of Pharmacy and Medical and Life Sciences","ror":"https://ror.org/00dnbtf70","country_code":"JP","type":"education","lineage":["https://openalex.org/I114838220"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kyoko Fukumoto","raw_affiliation_strings":["Department of Pharmaceutical Sciences, Niigata University of Pharmacy and Applied Life Sciences, Niigata, Japan","Department of Pharmaceutical Sciences, Niigata University of Pharmacy and Applied Life Sciences"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Sciences, Niigata University of Pharmacy and Applied Life Sciences, Niigata, Japan","institution_ids":["https://openalex.org/I114838220"]},{"raw_affiliation_string":"Department of Pharmaceutical Sciences, Niigata University of Pharmacy and Applied Life Sciences","institution_ids":["https://openalex.org/I114838220"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101447660","display_name":"Ryuji Kato","orcid":"https://orcid.org/0000-0002-7783-2599","observed_orcids":["https://orcid.org/0000-0002-7783-2599"]},"institutions":[{"id":"https://openalex.org/I90237989","display_name":"Osaka University of Pharmaceutical Sciences","ror":"https://ror.org/029yaft79","country_code":"JP","type":"education","lineage":["https://openalex.org/I205143321","https://openalex.org/I90237989"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ryuji Kato","raw_affiliation_strings":["Department of Clinical Pharmacology & Pharmacokinetics, Osaka University of Pharmaceutical Sciences, saka, Japan","Department of Clinical Pharmacology & Pharmacokinetics, Osaka University of Pharmaceutical Sciences"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology & Pharmacokinetics, Osaka University of Pharmaceutical Sciences, saka, Japan","institution_ids":["https://openalex.org/I90237989"]},{"raw_affiliation_string":"Department of Clinical Pharmacology & Pharmacokinetics, Osaka University of Pharmaceutical Sciences","institution_ids":["https://openalex.org/I90237989"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108772860","display_name":"Kazuhiko Tanaka","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I90237989","display_name":"Osaka University of Pharmaceutical Sciences","ror":"https://ror.org/029yaft79","country_code":"JP","type":"education","lineage":["https://openalex.org/I205143321","https://openalex.org/I90237989"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kazuhiko Tanaka","raw_affiliation_strings":["Department of Clinical Pharmacology & Pharmacokinetics, Osaka University of Pharmaceutical Sciences, saka, Japan","Department of Clinical Pharmacology & Pharmacokinetics, Osaka University of Pharmaceutical Sciences"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology & Pharmacokinetics, Osaka University of Pharmaceutical Sciences, saka, Japan","institution_ids":["https://openalex.org/I90237989"]},{"raw_affiliation_string":"Department of Clinical Pharmacology & Pharmacokinetics, Osaka University of Pharmaceutical Sciences","institution_ids":["https://openalex.org/I90237989"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101471743","display_name":"Kazuyuki Ueno","orcid":"https://orcid.org/0000-0001-8014-8109","observed_orcids":["https://orcid.org/0000-0001-8014-8109"]},"institutions":[{"id":"https://openalex.org/I114838220","display_name":"Niigata University of Pharmacy and Medical and Life Sciences","ror":"https://ror.org/00dnbtf70","country_code":"JP","type":"education","lineage":["https://openalex.org/I114838220"]}],"countries":["JP"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Kazuyuki Ueno","raw_affiliation_strings":["Department of Pharmaceutical Sciences, Niigata University of Pharmacy and Applied Life Sciences, Niigata, Japan","Department of Pharmaceutical Sciences, Niigata University of Pharmacy and Applied Life Sciences"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Sciences, Niigata University of Pharmacy and Applied Life Sciences, Niigata, Japan","institution_ids":["https://openalex.org/I114838220"]},{"raw_affiliation_string":"Department of Pharmaceutical Sciences, Niigata University of Pharmacy and Applied Life Sciences","institution_ids":["https://openalex.org/I114838220"]}]},{"author_position":"last","author":{"id":null,"display_name":"Miho Takagi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114838220","display_name":"Niigata University of Pharmacy and Medical and Life Sciences","ror":"https://ror.org/00dnbtf70","country_code":"JP","type":"education","lineage":["https://openalex.org/I114838220"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Miho Takagi","raw_affiliation_strings":["Department of Pharmaceutical Sciences, Niigata University of Pharmacy and Applied Life Sciences"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Sciences, Niigata University of Pharmacy and Applied Life Sciences","institution_ids":["https://openalex.org/I114838220"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5101471743"],"corresponding_institution_ids":["https://openalex.org/I114838220"],"apc_list":{"value":3580,"currency":"USD","value_usd":3580},"apc_paid":null,"fwci":2.1713,"has_fulltext":false,"cited_by_count":25,"citation_normalized_percentile":{"value":0.84431833,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":96},"biblio":{"volume":"23","issue":"2","first_page":"115","last_page":"119"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12910","display_name":"Eicosanoids and Hypertension Pharmacology","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bucolome","display_name":"bucolome","score":0.9509999752044678},{"id":"https://openalex.org/keywords/losartan","display_name":"losartan","score":0.9490000009536743},{"id":"https://openalex.org/keywords/cyp2c9-inhibition","display_name":"CYP2C9 inhibition","score":0.949999988079071},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.6930000185966492},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.765999972820282},{"id":"https://openalex.org/keywords/angiotensin-receptor-blockers","display_name":"angiotensin receptor blockers","score":0.9079999923706055},{"id":"https://openalex.org/keywords/carboxylic-acid-metabolites","display_name":"carboxylic acid metabolites","score":0.7910000085830688},{"id":"https://openalex.org/keywords/human-volunteers","display_name":"human volunteers","score":0.5109999775886536},{"id":"https://openalex.org/keywords/rats","display_name":"rats","score":0.5559999942779541}],"concepts":[{"id":"https://openalex.org/C2780288358","wikidata":"https://www.wikidata.org/wiki/Q410074","display_name":"Losartan","level":4,"score":0.989445149898529},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.8431347608566284},{"id":"https://openalex.org/C3946865","wikidata":"https://www.wikidata.org/wiki/Q5014962","display_name":"CYP2C9","level":4,"score":0.7481920719146729},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6489746570587158},{"id":"https://openalex.org/C2776768635","wikidata":"https://www.wikidata.org/wiki/Q3427301","display_name":"Volunteer","level":2,"score":0.6085615754127502},{"id":"https://openalex.org/C87813604","wikidata":"https://www.wikidata.org/wiki/Q1242899","display_name":"Crossover study","level":4,"score":0.6053705811500549},{"id":"https://openalex.org/C2780708007","wikidata":"https://www.wikidata.org/wiki/Q285044","display_name":"Angiotensin II receptor antagonist","level":5,"score":0.5339020490646362},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.5268836617469788},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5013096332550049},{"id":"https://openalex.org/C2777056448","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Oral administration","level":2,"score":0.4236880838871002},{"id":"https://openalex.org/C2908929049","wikidata":"https://www.wikidata.org/wiki/Q65963433","display_name":"Angiotensin II","level":3,"score":0.40824130177497864},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3805631399154663},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.31316083669662476},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.29160577058792114},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.27033859491348267},{"id":"https://openalex.org/C62231903","wikidata":"https://www.wikidata.org/wiki/Q1057","display_name":"Metabolism","level":2,"score":0.12493324279785156},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.09147316217422485},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.05738362669944763},{"id":"https://openalex.org/C526171541","wikidata":"https://www.wikidata.org/wiki/Q407693","display_name":"Cytochrome P450","level":3,"score":0.04141950607299805},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C6557445","wikidata":"https://www.wikidata.org/wiki/Q173113","display_name":"Agronomy","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001189","descriptor_name":"Aryl Hydrocarbon Hydroxylases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D001463","descriptor_name":"Barbiturates","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001682","descriptor_name":"Biological Availability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017208","descriptor_name":"Rats, Wistar","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018592","descriptor_name":"Cross-Over Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019808","descriptor_name":"Losartan","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D047228","descriptor_name":"Angiotensin II Type 1 Receptor Blockers","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D065729","descriptor_name":"Cytochrome P-450 CYP2C9","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.2133/dmpk.23.115","doi":"https://doi.org/10.2133/dmpk.23.115","is_oa":false,"landing_page_url":"https://doi.org/10.2133/dmpk.23.115","pdf_url":null,"source":{"id":"https://openalex.org/S185835163","display_name":"Drug Metabolism and Pharmacokinetics","issn_l":"1347-4367","issn":["1347-4367","1880-0920"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Metabolism and Pharmacokinetics","raw_type":"journal-article"},{"id":"pmid:18445991","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18445991","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug metabolism and pharmacokinetics","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":15,"referenced_works":["https://openalex.org/W1543348686","https://openalex.org/W1703321169","https://openalex.org/W1939958183","https://openalex.org/W1967305865","https://openalex.org/W1972212193","https://openalex.org/W1981658210","https://openalex.org/W1990952432","https://openalex.org/W2006635565","https://openalex.org/W2013571586","https://openalex.org/W2084760694","https://openalex.org/W2097712021","https://openalex.org/W2109166286","https://openalex.org/W2145879452","https://openalex.org/W2326493103","https://openalex.org/W2435937398"],"related_works":["https://openalex.org/W3162781702","https://openalex.org/W2330189169","https://openalex.org/W2025223069","https://openalex.org/W2071240356","https://openalex.org/W2072673226","https://openalex.org/W2109166286","https://openalex.org/W2012019137","https://openalex.org/W2085868762","https://openalex.org/W2078293971","https://openalex.org/W2563244473"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2082201249","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2021,"cited_by_count":3},{"year":2018,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
